These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7726528

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro comparison of Staphylococcus pseudintermedius susceptibility to common cephalosporins used in dogs.
    Westermeyer RR, Roy AF, Mitchell MS, Merchant SR.
    Vet Ther; 2010; 11(3):E1-9. PubMed ID: 20960413
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
    Doern GV, Brueggemann A, Holley HP, Rauch AM.
    Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Bryson HM, Brogden RN.
    Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro activities of LY163892, cefaclor, and cefuroxime.
    Knapp CC, Washington JA.
    Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
    Arguedas AG, Arrieta AC, Stutman HR, Akaniro JC, Marks MI.
    J Antimicrob Chemother; 1991 Mar; 27(3):311-8. PubMed ID: 1903788
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Mar; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 38. Cefdinir: an oral alternative to parenteral cephems.
    Chatterjee A, Moland ES, Thomson KS.
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):259-64. PubMed ID: 15808317
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella.
    Jones RN, Erwin ME, Barrett MS.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(6):519-21. PubMed ID: 1802542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.